ArticleNature communications2018
Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.
Valeriy Domenyuk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this papercites it